RxDoctor Payments DataLook up a doctor →

Lori Brent

Family · Jackson, MSNPI 1992958169

Payments from drug & device makers

$11,459in general payments, 2019–2025

Across 590 payments — averaging $19.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • Merck$672
  • Genentech USA, Inc.$584
  • AstraZeneca$578
  • Gilead$519
  • Pfizer$472
  • plus $7K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis66$1,603
Merck33$672
Genentech USA, Inc.35$584
AstraZeneca37$578
Gilead(2 entities)25$519
Pfizer31$472
Bristol Myers Squibb25$458
Amgen20$453
Sanofi22$424
Johnson & Johnson28$405
Incyte Corporation22$343
Daiichi Sankyo Inc.12$295
Takeda Pharmaceuticals U.S.A., Inc.15$285
AbbVie11$276
Lilly USA, LLC15$265
Deciphera Pharmaceuticals Inc.11$225
Astellas Pharma US Inc12$205
AVEO Pharmaceuticals, Inc.7$205
Beigene USA, Inc.10$195
E.r. Squibb & Sons, L.L.C.11$194
Stemline Therapeutics Inc.8$190
Rigel Pharmaceuticals, Inc.9$159
Tersera Therapeutics LLC5$150
Pharmaessentia USA Corporation6$143
EMD Serono, Inc.7$139
Sanofi-aventis U.S. LLC3$127
Sobi, Inc5$125
Ipsen Biopharmaceuticals, Inc5$116
Seagen Inc.7$115
Pharmacyclics LLC, An Abbvie Company8$115
Eisai Inc.6$107
Bayer4$97
Puma Biotechnology, Inc.6$94
GSK5$89
Mirati Therapeutics, Inc.5$87
Blueprint Medicines Corporation5$82
Karyopharm Therapeutics Inc.5$77
Array Biopharma Inc4$72
Regeneron Healthcare Solutions, Inc.3$58
Jazz Pharmaceuticals Inc.3$57
Apellis Pharmaceuticals, Inc.4$57
Boehringer Ingelheim3$53
Taiho Oncology, Inc.2$41
Exelixis Inc.2$40
Genmab U.S., Inc.2$33
Coherus Oncology, Inc.2$33
G1 Therapeutics, Inc.2$32
Morphosys, US Inc.1$31
Janssen Scientific Affairs, LLC1$28
Pharmacosmos Therapeutics Inc.1$28
Springworks Therapeutics, Inc.1$23
Sanofi US Services Inc.1$23
Adaptive Biotechnologies Corporation1$22
Sanofi Pasteur Inc.1$19
Recordati_rare_diseases_inc.1$19
Iovance Biotherapeutics, Inc.1$19
Legend Biotech USA Inc.1$18
Servier Pharmaceuticals LLC1$16
Pharming Healthcare, Inc.1$16
Novocure Inc.1$15

How this compares

$11,459 in reported general payments places this provider in the 95th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$3,271
Medicare patients
30
Services billed
31

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →